ACNM/SNMMI Webinar Series - PET/CT Pitfalls and Pearls for the Interpretation of Squamous Cell Carcinoma of the Head and Neck
ACNM/SNMMI Webinar Series - PET/CT Pitfalls and Pearls for the Interpretation of Squamous Cell Carcinoma of the Head and Neck
ACNM/SNMMI Webinar Series - PET/CT Pitfalls and Pearls for the Interpretation of Squamous Cell Carcinoma of the Head and Neck

Technologist (VOICE) Member Fee: Free
Technologist (VOICE) Non-Member Fee: $32.00

Pharmacist (ACPE) Member Fee: Free
Pharmacist (ACPE) Non-Member Fee: $40.00

Release Date: February 23, 2016
Expiration Date: February 28, 2019

Presenter

Sara Meibom, MD 

Financial Disclosure

In accordance with ACCME Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the speaker has indicated no relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.

Target Audience
Physicians, pharmacists, and technologists

Objectives 
At the completion of this activity, the participant will be able to:
  • - Describe the role of PET/CT in initial staging head and neck squamous cell cancer to identify the primary cancer and to find metastatic disease.
  • Discuss the importance of proper head and neck PET/CT acquisition to improve disease detection.
  • Identify and report adverse features that result in a worse prognosis such as lymph node metastasis, extracapsular spread, perineural invasion, encasement of the carotid artery, invasion into surrounding structures.
  • Identify key findings, such as: denervated benign tissue, blooming artifact, attenuation correction artifact, altered biodistribution and thermogenic brown fat.
  • Identify necrotic nonFDG avid nodes as metastatic.
  • Explain why oral contrast ingestion can cause false positive uptake in the tongue.
  • Describe the TNM staging of oral cavity cancer.

Continuing Education Credit Information

Image result for ACPE logo

Pharmacist (ACPE):
The Society for Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE.  To receive CE credit, learners must first complete the activity content, achieve a score of 80% on the post-course assessment and complete the evaluation. Learners will have no more than 3 attempts to successfully complete the post-test. This activity must be completed by the expiration date listed above. The universal program number for this meeting is 0210-0000-16-061-L04-P. Total available credit for pharmacists is 1.0 hours or 0.1 CEUs.


Technolgist (VOICE): 
The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this meeting for a maximum of 1.0 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A+ credit. To receive CE credit, learners must first complete the activity content, achieve a score of 80% on the post-course assessment and complete the evaluation.  Learners will have no more than 3 attempts to successfully complete the post-test. This activity must be completed by the expiration date listed above. California Scope: 1.0 Imaging (I)

Minimum system requirements

Supported Internet Browsers:
- Microsoft Internet Explorer (version 7 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)
- Apple Safari (version 4 or higher)

Plug-in: Adobe Acrobat Reader (http://get.adobe.com/reader/) 

For questions please contact the Education Department 703-708-9000.
© 2016 SNMMI. All rights reserved. 

For more information on our privacy policy, please click the link below. 

Type:     Internet Activity (Enduring Material)
290 Registered Users